RNA vaccines seem to produce very different antibody levels

Enlarge / A phlebotomist draws blood meant for antibody testing.Frederic J. Brown / Getty Images

We’ve tended to treat the RNA-based vaccines from Moderna and Pfizer/BioNTech as functionally equivalent. They take an identical approach to producing immunity and have a very similar set of ingredients. Clinical trial data suggested they had very similar efficacy—both in the area of 95 percent.

So it was a bit of a surprise to have a paper released yesterday indicating that the two produce an antibody response that’s easy to distinguish, with Moderna inducing antibody levels that were more than double that seen among people who received the Pfizer/BioNTech shot. While it’s important not to

→ Continue reading at Ars Technica

Related articles

Comments

Share article

Latest articles